Which medicine works best for fatty liver disease?
Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
FGF-21 analogues were most effective for liver stiffness, not GLP-1 drugs
Most attention has been on GLP-1 drugs like semaglutide for liver disease, but this study suggests FGF-21 may be superior for fibrosis—a key surprise.
Practical Takeaways
People with MASLD may benefit from newer GLP-1-based polyagonists for reducing liver fat, especially if fat accumulation is the main concern.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
FGF-21 analogues were most effective for liver stiffness, not GLP-1 drugs
Most attention has been on GLP-1 drugs like semaglutide for liver disease, but this study suggests FGF-21 may be superior for fibrosis—a key surprise.
Practical Takeaways
People with MASLD may benefit from newer GLP-1-based polyagonists for reducing liver fat, especially if fat accumulation is the main concern.
Publication
Journal
Metabolism: clinical and experimental
Year
2024
Authors
Rutao Lin, Qin-mei Sun, Xin Xin, Cheng Han Ng, Luca Valenti, Yi-Yang Hu, Ming-Hua Zheng, Qin Feng
Related Content
Claims (6)
Your body makes a hormone called FGF-21 when under stress, and it helps control how sensitive you are to insulin and how much belly fat you store — but how and how long it’s turned on really matters.
A type of diabetes drug called GLP-1 agonists might help people with fatty liver disease by reducing liver fat, improving blood sugar, and helping with weight loss—based on early study results.
A new type of diabetes-like drug called GLP-1 polyagonists might be the best option we have for clearing fat from the liver in people with a common liver condition, and studies suggest it works way better than other medicines.
A type of drug related to a hormone called FGF-21 might be the best option for helping reduce liver scarring in adults with a common liver disease, and early results suggest it works better than other treatments.
A certain type of drug called THR-β agonists might help improve both fatty liver and liver scarring in adults with MASLD, and it also seems to help with cholesterol and fats in the blood—making it a two-in-one treatment for liver and metabolism.